1. Liu Z., Zhang Y., Ma N., Yang Y., Ma Y., Wang F., Wang Y., Wei J., Chen H., Tartarone A., Velotta J. B., Dayyani F., Gabriel E., Wakefield C. J., Kidane B., Carbonelli C., Long L.*, Liu Z.*, Su J.*, Li Z*. (2023) Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell 41 (11), 1852-1870. e9 (* co-corresponding author)

2. Xia J., Ma N., Shi Q., Liu Q. C., Zhang W., Cao H. J., Wang Y. K., Zheng Q. W., Ni Q. J., Xu S., Zhu B., Qiu X. S., Ding K., Huang J. Y., Liang X., Chen Y., Xiang Y. J., Zhang X. R., Qiu L., Chen W., Xie D., Wang X., Long L.*, Li J. J*. (2023) XAF1 promotes colorectal cancer metastasis via VCP–RNF114–JUP axis. Journal of Cell Biology 223 (2), e202303015 (* co-corresponding author)

3. Long L.#, Wei J., Lim S. A., Raynor J. L., Shi H., Connelly J. P., Wang H., Guy C., Xie B., Chapman N. M., Fu G., Wang Y., Huang H., Su W., Saravia J., Risch I., Wang Y. D., Li Y., Niu M., Dhungana, Y., Kc, A., Zhou, P., Vogel, P., Yu, J., Pruett-Miller, S. M., Peng, J., Chi, H*. (2021) CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity. Nature 600,308-313

4. Wei, J.#, Long, L.#, Zheng W., Dhungana, Y., Lim, S. A., Guy, C., Wang, Y., Wang, Y., Qian, C., Xu, B., Kc, A., Saravia, J., Huang, H., Yu, J., Doench, J. G., Geiger, T. L., Chi, H*. (2019) Targeting Regnase-1 programs long-lived effector T cells for cancer therapy. Nature 576(7787):471-476 (# co-first author)

5. Long, L.#, Deng, Y., Yao, F., Guan, D., Feng, Y., Jiang, H., Li, X., Hu, P., Lu, X., Wang, H., Li, J., Gao, X., Xie, D*. (2014) Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 40:515-529

6. Huang, H., Zhou, P., Wei, J., Long, L., Shi, H., Dhungana, Y., Chapman, N. M., Fu, G., Saravia, J., Raynor, J. L., Liu, S., Palacios, G., Wang, Y. D., Qian, C., Yu, J., Chi, H*. (2021) In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8(+) T cell fate decisions. Cell 2021 Mar 4;184(5):1245-1261.e21

7. Fu, G., Guy, C. S., Chapman, N. M., Palacios, G., Wei, J., Zhou, P., Long, L., Wang, Y. D., Qian, C., Dhungana, Y., Huang, H., Kc, A., Shi, H., Rankin, S., Brown, S. A., Johnson, A., Wakefield, R., Robinson, C. G., Liu, X., Sheyn, A., Yu, J., Jackowski, S., Chi, H*. (2021) Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine. Nature 2021 Jul;595(7869):724-729

8. Lim, S. A., Wei, J., Nguyen, T. M., Shi, H., Su, W., Palacios, G., Dhungana, Y., Chapman, N. M., Long, L., Saravia, J., Vogel, P., Chi, H*. (2021) Lipid signalling enforces functional specialization of Treg cells in tumours. Nature 2021 Mar;591(7849):306-311

9. Zheng, W., Wei, J., Zebley, C., Jones, Long, L., Dhungana, Y., Wang, Y. D., Mavuluri, J., Long, L., Fan, Y., Youngblood, B., Chi, H., Geiger, T. L*. (2021) Regnase-1 suppresses TCF-1+ precursor exhausted T cell formation to limit CAR T cell responses against ALL. Blood 138(2):122-135.

10. Su, W., Chapman, N. M., Wei, J., Zeng, H., Dhungana, Y., Shi, H., Saravia, J., Zhou, P., Long, L., Rankin, S., Kc, A., Vogel, P., Chi, H*. (2020) Protein Prenylation Drives Discrete Signaling Programs for the Differentiation and Maintenance of Effector Treg Cells. Cell Metab 2020 Dec 1;32(6):996-1011.e7

11. Huang, H., Long, L., Zhou, P., Chapman, N. M., Chi, H*. (2020) mTOR signaling at the crossroads of environmental signals and T-cell fate decisions. Immunol Rev 2020 May;295(1):15-38

12. Shi, H., Chapman, N. M., Wen, J., Guy, C., Long, L., Dhungana, Y., Rankin, S., Pelletier, S., Vogel, P., Wang, H., Peng, J., Guan, K. L., Chi, H*. (2019) Amino Acids License Kinase mTORC1 Activity and Treg Cell Function via Small G Proteins Rag and Rheb. Immunity 2019 Dec 17;51(6):1012-1027.e7

13. Wang, Y., Du, X., Wei, J., Long, L., Tan, H., Guy, C., Dhungana, Y., Qian, C., Neale, G., Fu, Y. X., Yu, J., Peng, J., Chi, H*. (2019) LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity. Cell Res 2019 May;29(5):391-405

14. Yang, K., Blanco, D. B., Neale, G., Vogel, P., Avila, J., Clish, C. B., Wu, C., Shrestha, S., Rankin, S., Long, L., Kc, A., Chi, H*. (2017) Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling. Nature 548, 602-606

15. Karmaus, P. W. F., Herrada, A. A., Guy, C., Neale, G., Dhungana, Y., Long, L., Vogel, P., Avila, J., Clish, C. B., Chi, H*. (2017) Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis. J Exp Med 214, 2629-2647

16. Li, J. J., Sun, Z. J., Yuan, Y. M., Yin, F. F., Bian, Y. G., Long, L. Y., Zhang, X. L., Xie, D. (2017) EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer. J Biol Chem 292, 1112-1121

17. Wei, J., Long, L., Yang, K., Guy, C., Shrestha, S., Chen, Z., Wu, C., Vogel, P., Neale, G., Green, D. R., Chi, H*. (2016) Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat Immunol 17, 277-285

18. Bao, W. D., Fan, Y., Deng, Y. Z., Long, L. Y., Wang, J. J., Guan, D. X., Qian, Z. Y., An, P., Feng, Y. Y., He, Z. Y., Wang, X. F., Phillip Koeffler, H., Hu, R., Wang, J., Wang, X., Wang, F., Li, J. J., Xie, D*. (2016) Iron overload in hereditary tyrosinemia type 1 induces liver injury through the Sp1/Tfr2/hepcidin axis. J Hepatol 65, 137-145

19. Guan, D. X., Shi, J., Zhang, Y., Zhao, J. S., Long, L. Y., Chen, T. W., Zhang, E. B., Feng, Y. Y., Bao, W. D., Deng, Y. Z., Qiu, L., Zhang, X. L., Koeffler, H. P., Cheng, S. Q., Li, J. J., Xie, D*. (2015) Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade. Hepatology 62, 1791-1803

20. Yao, F., Long, L. Y., Deng, Y. Z., Feng, Y. Y., Ying, G. Y., Bao, W. D., Li, G., Guan, D. X., Zhu, Y. Q., Li, J. J., Xie, D*. (2014) RACK1 modulates NF-kappaB activation by interfering with the interaction between TRAF2 and the IKK complex. Cell Res 24, 359-371

21. Deng, Y. Z., Yao, F., Li, J. J., Mao, Z. F., Hu, P. T., Long, L. Y., Li, G., Ji, X. D., Shi, S., Guan, D. X., Feng, Y. Y., Cui, L., Li, D. S., Liu, Y., Du, X., Guo, M. Z., Xu, L. Y., Li, E. M., Wang, H. Y., Xie, D*. (2012) RACK1 suppresses gastric tumorigenesis by stabilizing the beta-catenin destruction complex. Gastroenterology 142, 812-823 e815